Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-04-01
著者
-
Yamanouchi Jun
Department Of Biomedical Science Graduate School Of Agricultural And Life Sciences The University Or
-
Yamanouchi Jun
Departments Of Bioregulatory Medicine And Blood Transfusion And Cell Therapy Ehime University Gradua
-
SHIKATA Hisaharu
Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine
-
Takeuchi Kazuhito
Department Of Frontier Materials Chemistry Graduate School Of Science And Technology Hirosaki Univer
-
Yakushijin Yoshihiro
Cancer Center Ehime University Graduate School Of Medicine
-
Hato Takaaki
Division Of Blood Transfusion And Cell Therapy Ehime University Graduate School Of Medicine
-
Azuma Taichi
Department Of Bioregulatory Medicine Ehime University Graduate School Of Medicine
-
Narumi Hiroshi
Department Of Bioregulatory Medicine Ehime University Graduate School Of Medicine
-
Yasukawa Masaki
Department Of Bioregulatory Medicine Ehime University Graduate School Of Medicine
-
Yasukawa Masaki
Department Of Bioregulatory Medicine Ehime University
-
Yasukawa Masaki
First Department Of Internal Medicine Ehime University School Of Medicine
-
TANIMOTO Kazushi
Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine
-
Shikata Hisaharu
Department Of Bioregulatory Medicine Ehime University Graduate School Of Medicine
-
Tanimoto Kazushi
Department Of Bioregulatory Medicine Ehime University Graduate School Of Medicine
-
Takaoka Ikue
Department Of Bioregulatory Medicine Ehime University Graduate School Of Medicine
-
Horikawa Tamami
Department Of Bioregulatory Medicine Ehime University Graduate School Of Medicine
関連論文
- Biological Activity of Some Cyanobiphenyl Derivatives
- The Effect of Probucol on Atherosclerosis in Streptozotocin-Induced Diabetic-Hyperlipidemic APA Hamsters in Different Stages of Atherosclerosis
- Expression of Lipoprotein Receptors in the Aortic Walls of Diabetic APA hamsters
- APA Hamster Model for Diabetic Atherosclerosis. 2. Analysis of Lipids and Lipoproteins
- Aortic Atheromatous Lesions Developed in APA Hamsters with Streptozotocin induced Diabetes: A New Animal Model for Diabetic Atherosclerosis. 1. Histopathological Studies
- Allogeneic stem cell transplantation for refractory adult T-cell leukemia using a non-T-cell-depleted HLA-incompatible family donor graft, with reference to the grown-up child donor to parent recipient setting : report of a pilot study
- Existence of Leukemic Clones Resistant to Both Imatinib Mesylate and Rituximab before Drug Therapies in a Patient with Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia
- Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan
- Mutations of syntaxin 11 and SNAP23 genes as causes of familial hemophagocytic lymphohistiocytosis were not found in Japanese people
- Outside-in signaling from integrin α_β_3 into platelets in the absence of agonist-induced signaling
- Follicular dendritic cell tumor as an unknown primary tumor
- Single-Dose Daily Infusion of Cyclosporine for Prevention of Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation from HLA Allele-Matched, Unrelated Donors
- Age-Related Histochemical and Ultrastructural Changes in Renal Glomerular Mesangium of APA Hamsters
- Myeloid sarcoma in essential thrombocythemia that transformed into acute myeloid leukemia
- Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
- WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
- Wilms Tumor Gene Peptide-Based Immunotherapy for Patients with Overt Leulemia from Myelodysplastic Syndrome (MDS) or MDS with Myelofibrosis
- Rupture of the Gallbladder in a Patient with Acquired Factor VIII Inhibitors and Systemic Lupus Erythematosus
- Expression of the Gfi-1 Gene in HTLV-I-Transformed T Cells
- Multiple Diffuse Fibrosarcoma of Bone Associated with Extramedullary Hematopoiesis
- Non-Hodgkin's Lymphoma Developing in a Pacemaker Pocket
- Compound heterozygous mutations in the PROS1 gene responsible for quantitative and qualitative protein S deficiency
- Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma
- Identification of an epitope derived from CML66, a novel tumor-associated antigen expressed broadly in human leukemia, recognized by human leukocyte antigen-A^*2402-restricted cytotoxic T lymphocytes
- Absence of Chlamydial Infection in Japanese Patients with Ocular Adnexal Lymphoma of Mucosa-Associated Lymphoid Tissue
- Leukemoid Reaction in Association with Bone Marrow Necrosis due to Metastatic Prostate Cancer
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- A case of chronic myeloid leukemia with eosinophilic interstitial pneumonitis after administration of imatinib mesylate for 11 months
- IgG4-Related Disease : A Novel Lymphoproliferative Disorder Discovered and Established in Japan in the 21st Century
- Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis
- Impairment of protein C secretion in protein C-deficient patients carrying an Asp297 mutation
- Syndrome of inappropriate secretion of antidiuretic hormone induced by tacrolimus in a patient with systemic lupus erythematosus
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
- A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- A new four-way variant t(5;17;15;20)(q33;q12;q22;q11.2) in acute promyelocytic leukemia
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement : The Nagasaki Transplant Group experience
- Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma
- Late effect of Atomic bomb radiation on myeloid disorders : leukemia and myelodysplastic syndromes
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Pneumomediastinum and Massive Subcutaneous Emphysema Associated with Dermatomyositis
- Multiple Tumoral Calcinosis in Systemic Sclerosis